Detecting T‐cell receptor clonality in patients with severe atopic dermatitis refractory to dupilumab

Documenti analoghi

• Efficacy and tolerance of dupilumab in patients with moderate‐to‐severe atopic dermatitis and obesity
  di: Joséphine Dupuis, et al.
  Pubblicazione: (2024)
• Bridging the gap: Treatment of atopic dermatitis with dupilumab during pregnancy
  di: Christian Vestergaard, et al.
  Pubblicazione: (2025)
• Comment on ‘Efficacy and tolerance of dupilumab in patients with moderate‐to‐severe atopic dermatitis and obesity’ by Dupuis et al.
  di: Luca Potestio, et al.
  Pubblicazione: (2024)
• Drug survival of abrocitinib compared to dupilumab in adult patients with atopic dermatitis
  di: Qingjie Hu, et al.
  Pubblicazione: (2024)
• Single‐centre experience with tralokinumab in dupilumab‐experienced and naïve patients with atopic dermatitis
  di: Claire Fossati, et al.
  Pubblicazione: (2024)